Full name
PHARMACARE POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
49.41.Z - Road freight transport
52.10.B - Warehousing and storage of other goods
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 293,2 | |||
Gross profit (loss) | 0,2 | 0,3 | 0,2 | -24,3 |
EBITDA | 445,2 | |||
Short time liabilities | 956,2 | |||
Income tax | 0 | 0 | 0 | -27,1 |
Other operating costs | 8217,1 | |||
Equity capital | 0,3 | 0,3 | 0,3 | -16,4 |
Operating profit (EBIT) | 304,2 | |||
Assets | 1 | 1,1 | 1,1 | -0,5 |
Net profit (loss) | 0,2 | 0,2 | 0,2 | -24 |
Cash | 8 300 095,3 | |||
Net income from sale | 92,9 | |||
Liabilities and provisions for liabilities | 0,7 | 0,7 | 0,8 | 6,9 |
Working assets | 1 | 1 | 1 | 0,1 |
Other income costs | 144,6 | |||
Basic operational activity income | 3,4 | 3,6 | 3,9 | 9,2 |
Depreciation | -3,8 | |||
% | % | % | p.p. | |
Profitability of capital | 62,8 | 68,4 | 62,2 | -6,2 |
Equity capital to total assets | 28,7 | 31,8 | 26,7 | -5,1 |
Gross profit margin | 5,9 | 7,1 | 4,9 | -2,2 |
EBITDA Margin | 5,9 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 267 | |||
Current financial liquidity indicator | 0,5 | |||
Net dept to EBITDA | 2,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane